News
Important Only
Stocks
Is Boeing an Undervalued Dividend Stock?
Boeing (NYSE: BA) has been plagued with challenges hurting its ability to build and sell planes.Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »*Stock prices used were the afternoon prices of Feb. 13, 2025. The video was published on Feb. 15...The Motley Fool
Tue, Feb 18
Other
Lockmaker Allegion beats quarterly estimates on strong demand for security devices
Feb 18 (Reuters) - Allegion ALLE.N reported fourth-quarter revenue and profit above Wall Street estimates on Tuesday, driven by strong demand for its locks, keys and electronic security systems used in residential and commercial buildings.Allegion benefited from an increase in demand for the company...Reuters
Tue, Feb 18
Other
Egypt president to travel to Riyadh for discussions on Arab plan for Gaza, sources say
CAIRO, Feb 18 (Reuters) - Egypt's President Abdel Fattah al-Sisi is expected to travel to Riyadh on Thursday for discussions on an Arab plan for Gaza, two Egyptian security sources said.Arab states are expected to discuss a post-war plan for Gaza reconstruction, possibly to counter U.S. Presiden...Reuters
Tue, Feb 18
Stocks
LIVE MARKETS-Positive earnings revisions, EPS upgrades fuel STOXX strength
STOXX 600 up 0.1%US and Russia meet over UkraineWall St returns from holidayNasdaq futures up 0.4%Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comPOSITIVE EARNINGS REVISIONS, EPS UPGR...Reuters
Tue, Feb 18
Other
BRIEF-Piramal Pharma Says US FDA Inspection At Turbhe Facility
Feb 18 (Reuters) - Piramal Pharma Ltd PIRM.NS:US FDA INSPECTION AT PIRAMAL PHARMA'S FACILITY LOCATED AT TURBHEON CONCLUSION OF INSPECTION, A FORM-483 WAS ISSUED WITH 6 OBSERVATIONSSource text: ID:nBSE410CGnFurther company coverage: PIRM.NSReuters
Tue, Feb 18
Stocks
BUZZ-Canadian banks' 2025 outlook clouded by US tariffs risk, brokerages say
** Canadian banks are expected to post strong Q1 earnings next week, but their outlook for the rest of 2025 remains uncertain due to risk of a tariff war between the U.S. and other countries, say brokerages CIBC Capital Markets and Jefferies** CIBC downgrades Bank of Nova Scotia BNS.TO to 'neutr...Reuters
Tue, Feb 18
Other
Russia wants NATO to disavow 2008 promise to Ukraine, foreign ministry says
MOSCOW, Feb 18 (Reuters) - Russia wants NATO to disavow its 2008 promise to one day give Ukraine membership of the U.S.-led military alliance, Russian Foreign Ministry spokeswoman Maria Zakharova said on Tuesday.NATO membership for Ukraine is unacceptable for Russia but a simple refusal to accept Uk...Reuters
Tue, Feb 18
Stocks
Looking for a Rock-Solid Passive Income Stream? Check Out This 4.3%-Yielding Dividend Stock.
A high dividend yield can sometimes be a sign of a higher risk profile. Oftentimes, high-yield dividend stocks have weaker financial profiles, which puts their payouts at risk of a reduction if the company experiences a financial setback. However, that's not always the case. That's clear when consid...The Motley Fool
Tue, Feb 18
Cryptocurrencies
Tether Helps Guinea Explore Blockchain Tech; New Crypto Users Could Benefit from Best Wallet Token Presale
Yesterday, Tether (the $USDT stablecoin issuer) signed a Memorandum of Understanding (MoU) with Guinea to assist new crypto users from the African nation in exploring blockchain tech. The agreement is similar to one that Tether signed with Uzbekistan last year, which focused on providing new crypto ...Bitcoinist
Tue, Feb 18
Other
BRIEF-Chemours Outlook FY Adjusted EBITDA Between $825 Million And $975 Million
Feb 18 (Reuters) - Chemours Co CC.N:CHEMOURS: OUTLOOK FY ADJUSTED EBITDA BETWEEN $825 MILLION AND $975 MILLIONCHEMOURS: OUTLOOK FY CAPITAL EXPENDITURES BETWEEN $250 MILLION TO $300 MILLIONCHEMOURS: OUTLOOK Q1 CONSOLIDATED NET SALES TO BE FLAT TO SLIGHTLY DOWN SEQUENTIALLYCHEMOURS: QTRLY NET SALES OF...Reuters
Tue, Feb 18
Other
BRIEF-Genedx Holdings Corp FY 2025 Revenue Guidance Of $350M To $360M
Feb 18 (Reuters) - GeneDx Holdings Corp WGS.O:GENEDX HOLDINGS CORP: FY 2025 REVENUE GUIDANCE OF $350M TO $360M, EXOME/GENOME VOLUME AND REVENUE GROWTH OF AT LEAST 30%GENEDX HOLDINGS CORP - FOURTH QUARTER 2024 REVENUES GREW TO $95.3 MILLIONSource text: ID:nBwbXVKqqaFurther company coverage: WGS.OReuters
Tue, Feb 18
Other
BRIEF-Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application
Feb 18 (Reuters) - Alvotech SA ALVO.O:ALVOTECH AND TEVA ANNOUNCE FILING ACCEPTANCE OF U.S. BIOLOGICS LICENSE APPLICATION FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)ALVOTECH SA - REGULATORY APPROVAL FOR AVT06 EXPECTED BY Q4 2025Source text: ID:nGNX1fKZpRFurther company coverage: ALVO.OReuters
Tue, Feb 18
Forex
Sterling holds near two-month high after UK wage data
Updates in European mid-day tradeBy Greta Rosen Fondahn Feb 18 (Reuters) - Sterling eased on Tuesday but stayed close to its recent two-month highs, as data showed accelerating British wage growth, reinforcing bets for a cautious rate cut path ahead for the Bank of England, despite a weak economy...Reuters
Tue, Feb 18
Forex
BoE's Bailey hopes for less bond market volatility driven by US tariffs
Feb 18 (Reuters) - Bank of England Governor Andrew Bailey said on Tuesday he wanted to see less volatility in medium and longer-dated bond yields that have been driven up by speculation about the trade policies of U.S. President Donald Trump.British government borrowing costs surged and then eased i...Reuters
Tue, Feb 18
